McIver Introduces Bill to Develop a Standardized HPV Test for Men

Skip to content Close Home About Meet LaMonica Committees And Caucuses Our District Votes and Legislation Contact Email Me Newsletter Subscribe Office Locations Request An Appearance Media Press Releases In the News Press Kit Issues Education Environment Healthcare Housing LGBTQ+ Rights Reproductive Justice Small Business Transportation and Infrastructure Voting Rights Services Help With A Federal Agency Congressional Art Competition Commendations And Greetings Appropriations Requests Flags Grant Applications Internships Military Academy Nominations Congressional App Challenge Tours And Tickets Resources Close Mobile Site Search SEARCH Congresswoman LaMonica McIver About Meet LaMonica Committees And Caucuses Our District Votes and Legislation Contact Email Me Newsletter Subscribe Office Locations Request An Appearance Media Press Releases In the News Press Kit Issues Education Environment Healthcare Housing LGBTQ+ Rights Reproductive Justice Small Business Transportation and Infrastructure Voting Rights Services Help With A Federal Agency Congressional Art Competition Commendations And Greetings Appropriations Requests Flags Grant Applications Internships Military Academy Nominations Congressional App Challenge Tours And Tickets Resources Modal Search Button Mobile Site Search Submit Search MENU Facebook Logo Twitter Logo BlueSky Logo Youtube Logo Instagram Logo Home Media Press Releases May 20, 2026 McIver Introduces Bill to Develop a Standardized HPV Test for Men WASHINGTON, D.C . – Today, Congresswoman LaMonica McIver (NJ-10) introduced the Closing the HPV Testing Gap Act, a bill to direct a comprehensive study leading to the development of an HPV (Human Papillomavirus) diagnostic test for men. There is no FDA-approved HPV test for men. Men can carry and transmit HPV. This bill would begin the work needed to close this gap by paving the way for a standardized, noninvasive test for men. Reps. Troy A. Carter, Sr. (LA-02), Rob Menendez, Jr. (NJ-08), and Marc Veasey (TX-33) are co-leading this bill. HPV is the most commonly sexually transmitted infection in the United States, causing approximately 13 million infections each year. The absence of a male diagnostic pathway leads to sustained transmission patterns that directly impact women, particularly through increased cervical cancer risk and delayed detection in female patients. “For too long, women have been forced to deal with the consequences of a major gap in our healthcare system—the lack of a standardized male test for HPV,” said McIver. “HPV impacts millions of Americans every year, but there is still no approved test for men. That’s causing delayed detection and preventable cancers. People deserve the studies and tests needed to protect themselves and their loved ones. That’s why I’m introducing the Closing the HPV Testing Gap Act to help develop a reliable, noninvasive HPV test for men and close a gap that has put women’s health at risk for too long.” “The Closing the HPV Testing Gap Act addresses a critical need in our nation’s cancer prevention strategy by advancing research into standardized, noninvasive HPV testing for men,” said Carter, the Co-Chair of the Congressional Men’s Health Caucus. “Expanding early detection and prevention tools is essential to reducing HPV-related cancers, limiting transmission, strengthening protections for women’s health, and building a more equitable public health system. I want to thank my friend Rep. McIver for her leadership on this important legislation.” “As a Co-Chair of the Men’s Health Caucus, I am proud to co-lead the Closing the HPV Testing Gap Act,” said Menendez, also a Co-Chair of the Congressional Men’s Health Caucus. “I am joining Reps. McIver, Carter Sr., and Veasey in this effort because our national HPV prevention strategy has overlooked a serious gap for far too long, affecting both men and women. I am committed to working to close this gap and supporting a health care system that works for all Americans.” “Women should not bear the burden of HPV prevention alone,” said Veasey. “Without an FDA-approved HPV test for men, we are missing a critical opportunity to reduce transmission and better protect women from cervical cancer and other HPV-related diseases. The Closing the HPV Testing Gap Act will help us better understand how noninvasive testing for men can strengthen prevention, improve early detection, and build a more equitable approach to cancer prevention.” “The National Consumers League applauds Congresswoman LaMonica McIver and Representatives Troy A. Carter Sr., Rob Menendez Jr., and Marc Veasey for introducing legislation to address a critical gap in our nation’s HPV prevention strategy,” said Sally Greenberg, Chief Executive Officer, National Consumers League. “While women have long borne the burden of HPV-related screening and follow-up care, the absence of an FDA-approved HPV test for men has left an important piece of the prevention puzzle missing. Advancing research into noninvasiv